These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36387898)

  • 1. Interleukin 6 receptor is not directly involved in regulation of body weight in diet-induced obesity with and without physical exercise.
    Minafra AR; Chadt A; Rafii P; Al-Hasani H; Behnke K; Scheller J
    Front Endocrinol (Lausanne); 2022; 13():1028808. PubMed ID: 36387898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Soluble IL-6 Receptor Concentration and Visceral Adipocyte Size Are Related to Insulin Resistance in Taiwanese Adults with Morbid Obesity.
    Kuo FC; Huang YH; Lin FH; Hung YJ; Hsieh CH; Lu CH; Su SC; Huang CL; Lee CH; Chu NF
    Metab Syndr Relat Disord; 2017 May; 15(4):187-193. PubMed ID: 28346858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The classic signalling and trans-signalling of interleukin-6 are both injurious in podocyte under high glucose exposure.
    Lei CT; Su H; Ye C; Tang H; Gao P; Wan C; He FF; Wang YM; Zhang C
    J Cell Mol Med; 2018 Jan; 22(1):251-260. PubMed ID: 28881473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking IL-6 trans-signaling prevents high-fat diet-induced adipose tissue macrophage recruitment but does not improve insulin resistance.
    Kraakman MJ; Kammoun HL; Allen TL; Deswaerte V; Henstridge DC; Estevez E; Matthews VB; Neill B; White DA; Murphy AJ; Peijs L; Yang C; Risis S; Bruce CR; Du XJ; Bobik A; Lee-Young RS; Kingwell BA; Vasanthakumar A; Shi W; Kallies A; Lancaster GI; Rose-John S; Febbraio MA
    Cell Metab; 2015 Mar; 21(3):403-16. PubMed ID: 25738456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal interleukin 6 (IL-6) receptor stalk composition for IL-6 receptor shedding and IL-6 classic signaling.
    Baran P; Nitz R; Grötzinger J; Scheller J; Garbers C
    J Biol Chem; 2013 May; 288(21):14756-68. PubMed ID: 23564454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The balance of interleukin (IL)-6, IL-6·soluble IL-6 receptor (sIL-6R), and IL-6·sIL-6R·sgp130 complexes allows simultaneous classic and trans-signaling.
    Baran P; Hansen S; Waetzig GH; Akbarzadeh M; Lamertz L; Huber HJ; Ahmadian MR; Moll JM; Scheller J
    J Biol Chem; 2018 May; 293(18):6762-6775. PubMed ID: 29559558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6.
    Rose-John S
    Int J Biol Sci; 2012; 8(9):1237-47. PubMed ID: 23136552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-6 and its receptor: from bench to bedside.
    Scheller J; Rose-John S
    Med Microbiol Immunol; 2006 Dec; 195(4):173-83. PubMed ID: 16741736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Function and proteolytic generation of the soluble interleukin-6 receptor in health and disease.
    Schumertl T; Lokau J; Rose-John S; Garbers C
    Biochim Biophys Acta Mol Cell Res; 2022 Jan; 1869(1):119143. PubMed ID: 34626681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of classic signaling is a novel function of soluble glycoprotein 130 (sgp130), which is controlled by the ratio of interleukin 6 and soluble interleukin 6 receptor.
    Garbers C; Thaiss W; Jones GW; Waetzig GH; Lorenzen I; Guilhot F; Lissilaa R; Ferlin WG; Grötzinger J; Jones SA; Rose-John S; Scheller J
    J Biol Chem; 2011 Dec; 286(50):42959-70. PubMed ID: 21990364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cathepsin S provokes interleukin-6 (IL-6) trans-signaling through cleavage of the IL-6 receptor in vitro.
    Flynn CM; Garbers Y; Düsterhöft S; Wichert R; Lokau J; Lehmann CHK; Dudziak D; Schröder B; Becker-Pauly C; Rose-John S; Aparicio-Siegmund S; Garbers C
    Sci Rep; 2020 Dec; 10(1):21612. PubMed ID: 33303781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The soluble Interleukin 6 receptor: generation and role in inflammation and cancer.
    Chalaris A; Garbers C; Rabe B; Rose-John S; Scheller J
    Eur J Cell Biol; 2011; 90(6-7):484-94. PubMed ID: 21145125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Soluble Interleukin 6 Receptor: Advanced Therapeutic Options in Inflammation.
    Rose-John S
    Clin Pharmacol Ther; 2017 Oct; 102(4):591-598. PubMed ID: 28675418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of interleukin-6 and the interleukin-6 receptor on glucose transport in mouse skeletal muscle.
    Gray SR; Ratkevicius A; Wackerhage H; Coats P; Nimmo MA
    Exp Physiol; 2009 Aug; 94(8):899-905. PubMed ID: 19482899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased IL-6 and Potential IL-6 trans-signalling in the airways after an allergen challenge.
    Esnault S; Khosravi M; Kelly EA; Liu LY; Bochkov YA; Tattersall MC; Jarjour NN
    Clin Exp Allergy; 2021 Apr; 51(4):564-573. PubMed ID: 33471392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 mediates exercise-induced increase in insulin sensitivity in mice.
    Benrick A; Wallenius V; Asterholm IW
    Exp Physiol; 2012 Nov; 97(11):1224-35. PubMed ID: 22523382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenetic Interplay Between IL-6 and Tryptophan Metabolism in an Experimental Model of Obesity.
    Mondanelli G; Albini E; Orecchini E; Pallotta MT; Belladonna ML; Ricci G; Grohmann U; Orabona C
    Front Immunol; 2021; 12():713989. PubMed ID: 34394118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6 trans-signalling in chronic inflammation and cancer.
    Scheller J; Ohnesorge N; Rose-John S
    Scand J Immunol; 2006 May; 63(5):321-9. PubMed ID: 16640655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interleukin-6 receptor Asp358Ala single nucleotide polymorphism rs2228145 confers increased proteolytic conversion rates by ADAM proteases.
    Garbers C; Monhasery N; Aparicio-Siegmund S; Lokau J; Baran P; Nowell MA; Jones SA; Rose-John S; Scheller J
    Biochim Biophys Acta; 2014 Sep; 1842(9):1485-94. PubMed ID: 24878322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-guided optimization of the interleukin-6 trans-signaling antagonist sgp130.
    Tenhumberg S; Waetzig GH; Chalaris A; Rabe B; Seegert D; Scheller J; Rose-John S; Grötzinger J
    J Biol Chem; 2008 Oct; 283(40):27200-7. PubMed ID: 18650419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.